Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
$571.0K
18 trades · 7 insiders
Net · 90d
$-571.0K
Insiders on file
37
Daily buy vs sell · 90 days
■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| McNeill Jonathan | President and COO | 9 | $0 | $524.1K | 2026-09-18 |
| Brumm Joshua T | Chief Executive Officer, Director | 9 | $0 | $1.08M | 2026-09-18 |
| Pinkas Jan | Chief Scientific Officer | 7 | $0 | $46.7K | 2026-09-16 |
| Bispham Barbara Harlin | See Remarks | 6 | $0 | $44.1K | 2026-09-16 |
| Im Ellie Eunkyung | Chief Medical Officer | 6 | $0 | $44.2K | 2026-09-16 |
| Scalzo Richard William | Chief Financial Officer | 6 | $0 | $40.3K | 2026-09-16 |
| Lynch Ryan | See Remarks | 6 | $0 | $17.0K | 2026-09-16 |
| Fairmount Healthcare Fund II L.P. | Director, 10% Owner | 2 | $20.00M | $0 | 2026-07-16 |
| Balcom Alexandra | Director | 2 | $0 | $0 | 2026-06-02 |
| Moran Susan | Director | 2 | $0 | $0 | 2026-06-02 |
| Violin Jonathan | Director | 2 | $0 | $0 | 2026-06-02 |
| Harwin Peter Evan | Director, 10% Owner | 4 | $20.00M | $0 | 2026-06-02 |
| Lubner David Charles | Director | 2 | $0 | $0 | 2026-06-02 |
| Doughty Christopher Grant | Chief Business Officer | 3 | $0 | $0 | 2025-12-15 |
| BVF GP HOLDINGS LLC | 10% Owner | 6 | $0 | $0 | 2025-06-13 |
| GNI Hong Kong Ltd | 10% Owner | 4 | $0 | $0 | 2023-10-27 |
| Miller Seline E. | SVP Finance; Interim CFO & PAO | 4 | $3.0K | $0 | 2023-08-31 |
| Hunt Andrea | Director | 19 | $0 | $0 | 2023-08-31 |
| LAWLOR AUGUSTINE | Director | 28 | $0 | $423.3K | 2023-08-31 |
| USMAN NASSIM | President and CEO | 43 | $35.4K | $0 | 2023-08-31 |
| Blouse Grant E. | Chief Scientific Officer | 4 | $7.2K | $0 | 2022-08-09 |
| Ling Geoffrey M.D. | Director | 12 | $18.7K | $0 | 2022-01-07 |
| Williams Eddie | Director | 19 | $11.6K | $0 | 2022-01-07 |
| DESOUZA ERROL B | Director | 23 | $0 | $0 | 2021-10-01 |
| JEW JEANNE Y | Director | 1 | $0 | $0 | 2021-09-09 |
| Levy Howard | Chief Medical Officer | 26 | $29.0K | $1.9K | 2021-08-09 |
| TETLOW SHARON | Director | 5 | $0 | $0 | 2021-06-09 |
| Musil Clinton | Chief Financial Officer | 3 | $0 | $0 | 2021-02-08 |
| Cai Veronica | Controller | 4 | $8.2K | $0 | 2020-03-13 |
| Richard John P | Director | 11 | $18.0K | $0 | 2020-03-13 |
| Payne Fletcher | Chief Financial Officer | 18 | $20.0K | $0 | 2019-08-12 |
| HILL STEPHEN A | Director | 11 | $10.1K | $0 | 2018-09-06 |
| Deerfield Mgmt L.P. | 10% Owner | 10 | $0 | $2.19M | 2018-03-08 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10% Owner | 5 | $0 | $2.19M | 2018-03-08 |
| SELICK HAROLD E | Director | 19 | $0 | $0 | 2018-01-16 |
| Madison Edwin | Chief Scientific Officer | 9 | $0 | $0 | 2015-10-22 |
| Himawan Jeff | Director, 10% Owner | 12 | $0 | $0 | 2015-08-20 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| McNeill Jonathan | President and COO | S Sale | 2026-09-18 | 2026-09-18 | 3,839 | $16.71 | $64.1K | 134,588 | SEC↗ |
| Brumm Joshua T | Chief Executive Officer | S Sale | 2026-09-18 | 2026-09-18 | 7,837 | $16.71 | $131.0K | 271,765 | SEC↗ |
| McNeill Jonathan | President and COO | S Sale | 2026-09-18 | 2026-09-18 | 3,839 | $16.71 | $64.1K | 134,588 | SEC↗ |
| Brumm Joshua T | Chief Executive Officer, Dir | S Sale | 2026-09-18 | 2026-09-18 | 7,837 | $16.71 | $131.0K | 271,765 | SEC↗ |
| McNeill Jonathan | President and COO | S Sale | 2026-09-16 | 2026-09-18 | 731 | $17.90 | $13.1K | 138,427 | SEC↗ |
| Brumm Joshua T | Chief Executive Officer | S Sale | 2026-09-16 | 2026-09-18 | 1,610 | $17.90 | $28.8K | 279,602 | SEC↗ |
| Bispham Barbara Harlin | See Remarks | S Sale | 2026-09-16 | 2026-09-18 | 620 | $17.90 | $11.1K | 18,710 | SEC↗ |
| Scalzo Richard William | Chief Financial Officer | S Sale | 2026-09-16 | 2026-09-18 | 568 | $17.90 | $10.2K | 19,730 | SEC↗ |
| Im Ellie Eunkyung | Chief Medical Officer | S Sale | 2026-09-16 | 2026-09-18 | 623 | $17.90 | $11.2K | 21,446 | SEC↗ |
| Pinkas Jan | Chief Scientific Officer | S Sale | 2026-09-16 | 2026-09-18 | 658 | $17.90 | $11.8K | 21,581 | SEC↗ |
| Lynch Ryan | See Remarks | S Sale | 2026-09-16 | 2026-09-18 | 240 | $17.90 | $4.3K | 13,631 | SEC↗ |
| Lynch Ryan | See Remarks | S Sale | 2026-09-16 | 2026-09-18 | 240 | $17.90 | $4.3K | 13,631 | SEC↗ |
| Pinkas Jan | Chief Scientific Officer | S Sale | 2026-09-16 | 2026-09-18 | 658 | $17.90 | $11.8K | 21,581 | SEC↗ |
| Im Ellie Eunkyung | Chief Medical Officer | S Sale | 2026-09-16 | 2026-09-18 | 623 | $17.90 | $11.2K | 21,446 | SEC↗ |
| Scalzo Richard William | Chief Financial Officer | S Sale | 2026-09-16 | 2026-09-18 | 568 | $17.90 | $10.2K | 19,730 | SEC↗ |
| McNeill Jonathan | President and COO | S Sale | 2026-09-16 | 2026-09-18 | 731 | $17.90 | $13.1K | 138,427 | SEC↗ |
| Brumm Joshua T | Chief Executive Officer, Dir | S Sale | 2026-09-16 | 2026-09-18 | 1,610 | $17.90 | $28.8K | 279,602 | SEC↗ |
| Bispham Barbara Harlin | See Remarks | S Sale | 2026-09-16 | 2026-09-18 | 620 | $17.90 | $11.1K | 18,710 | SEC↗ |
| Fairmount Healthcare Fund II L | Director, 10% Owner | P Buy deriv | 2026-07-16 | 2026-07-20 | 525,897 | $14.50 | $7.63M | 2,294,037 | SEC↗ |
| Fairmount Healthcare Fund II L | Director, 10% Owner | P Buy | 2026-07-16 | 2026-07-20 | 853,450 | $14.50 | $12.38M | 3,601,316 | SEC↗ |
| Brumm Joshua T | Chief Executive Officer | S Sale | 2026-06-22 | 2026-06-23 | 42,305 | $17.99 | $761.1K | 281,212 | SEC↗ |
| McNeill Jonathan | President and COO | S Sale | 2026-06-22 | 2026-06-23 | 20,549 | $17.99 | $369.7K | 139,158 | SEC↗ |
| Im Ellie Eunkyung | Chief Medical Officer | S Sale | 2026-06-22 | 2026-06-23 | 1,219 | $17.99 | $21.9K | 22,069 | SEC↗ |
| Bispham Barbara Harlin | See Remarks | S Sale | 2026-06-22 | 2026-06-23 | 1,218 | $17.99 | $21.9K | 19,330 | SEC↗ |
| Scalzo Richard William | Chief Financial Officer | S Sale | 2026-06-22 | 2026-06-23 | 1,112 | $17.99 | $20.0K | 20,298 | SEC↗ |
| Pinkas Jan | Chief Scientific Officer | S Sale | 2026-06-22 | 2026-06-23 | 1,288 | $17.99 | $23.2K | 22,239 | SEC↗ |
| Lynch Ryan | See Remarks | S Sale | 2026-06-22 | 2026-06-23 | 465 | $17.99 | $8.4K | 13,871 | SEC↗ |
| Harwin Peter Evan | Director, 10% Owner | A Award deriv | 2026-06-02 | 2026-06-03 | 11,050 | — | $0 | 11,050 | SEC↗ |
| Moran Susan | Director | A Award deriv | 2026-06-02 | 2026-06-03 | 11,050 | — | $0 | 11,050 | SEC↗ |
| Balcom Alexandra | Director | A Award deriv | 2026-06-02 | 2026-06-03 | 11,050 | — | $0 | 11,050 | SEC↗ |
| Lubner David Charles | Director | A Award deriv | 2026-06-02 | 2026-06-03 | 11,050 | — | $0 | 11,050 | SEC↗ |
| Violin Jonathan | Director | A Award deriv | 2026-06-02 | 2026-06-03 | 11,050 | — | $0 | 11,050 | SEC↗ |
| Bispham Barbara Harlin | See Remarks | A Award deriv | 2025-12-15 | 2025-12-17 | 72,185 | — | $0 | 72,185 | SEC↗ |
| Lynch Ryan | See Remarks | A Award deriv | 2025-12-15 | 2025-12-17 | 33,512 | — | $0 | 33,512 | SEC↗ |
| Im Ellie Eunkyung | Chief Medical Officer | A Award deriv | 2025-12-15 | 2025-12-17 | 65,190 | — | $0 | 65,190 | SEC↗ |
| McNeill Jonathan | President and COO | A Award deriv | 2025-12-15 | 2025-12-17 | 78,029 | — | $0 | 78,029 | SEC↗ |
| Scalzo Richard William | Chief Financial Officer | A Award deriv | 2025-12-15 | 2025-12-17 | 57,688 | — | $0 | 57,688 | SEC↗ |
| Brumm Joshua T | Chief Executive Officer | A Award deriv | 2025-12-15 | 2025-12-17 | 180,467 | — | $0 | 180,467 | SEC↗ |
| Doughty Christopher Grant | Chief Business Officer | A Award deriv | 2025-12-15 | 2025-12-17 | 58,855 | — | $0 | 58,855 | SEC↗ |
| Pinkas Jan | Chief Scientific Officer | A Award deriv | 2025-12-15 | 2025-12-17 | 70,025 | — | $0 | 70,025 | SEC↗ |
| Bispham Barbara Harlin | See Remarks | A Award | 2025-12-15 | 2025-12-17 | 12,422 | — | $0 | 12,422 | SEC↗ |
| Bispham Barbara Harlin | See Remarks | A Award | 2025-12-15 | 2025-12-17 | 6,000 | — | $0 | 18,422 | SEC↗ |
| Lynch Ryan | See Remarks | A Award | 2025-12-15 | 2025-12-17 | 4,000 | — | $0 | 12,378 | SEC↗ |
| Lynch Ryan | See Remarks | A Award | 2025-12-15 | 2025-12-17 | 8,378 | — | $0 | 8,378 | SEC↗ |
| Im Ellie Eunkyung | Chief Medical Officer | A Award | 2025-12-15 | 2025-12-17 | 16,298 | — | $0 | 16,298 | SEC↗ |
| Im Ellie Eunkyung | Chief Medical Officer | A Award | 2025-12-15 | 2025-12-17 | 5,000 | — | $0 | 21,298 | SEC↗ |
| McNeill Jonathan | President and COO | A Award | 2025-12-15 | 2025-12-17 | 6,000 | — | $0 | 159,707 | SEC↗ |
| McNeill Jonathan | President and COO | A Award | 2025-12-15 | 2025-12-17 | 19,507 | — | $0 | 153,707 | SEC↗ |
| Scalzo Richard William | Chief Financial Officer | A Award | 2025-12-15 | 2025-12-17 | 5,000 | — | $0 | 19,422 | SEC↗ |
| Scalzo Richard William | Chief Financial Officer | A Award | 2025-12-15 | 2025-12-17 | 14,422 | — | $0 | 14,422 | SEC↗ |
| Brumm Joshua T | Chief Executive Officer | A Award | 2025-12-15 | 2025-12-17 | 10,000 | — | $0 | 323,517 | SEC↗ |
| Brumm Joshua T | Chief Executive Officer | A Award | 2025-12-15 | 2025-12-17 | 45,117 | — | $0 | 313,517 | SEC↗ |
| Doughty Christopher Grant | Chief Business Officer | A Award | 2025-12-15 | 2025-12-17 | 8,000 | — | $0 | 62,194 | SEC↗ |
| Doughty Christopher Grant | Chief Business Officer | A Award | 2025-12-15 | 2025-12-17 | 14,714 | — | $0 | 54,194 | SEC↗ |
| Pinkas Jan | Chief Scientific Officer | A Award | 2025-12-15 | 2025-12-17 | 17,507 | — | $0 | 17,507 | SEC↗ |
| Pinkas Jan | Chief Scientific Officer | A Award | 2025-12-15 | 2025-12-17 | 5,000 | — | $0 | 22,507 | SEC↗ |
| Brumm Joshua T | Chief Executive Officer | A Award deriv | 2025-12-08 | 2025-12-10 | 345,672 | — | $0 | 345,672 | SEC↗ |
| McNeill Jonathan | President and COO | A Award deriv | 2025-12-08 | 2025-12-10 | 172,836 | — | $0 | 172,836 | SEC↗ |
| Harwin Peter Evan | Director, 10% Owner | P Buy deriv | 2025-12-04 | 2025-12-08 | 131,434 | $13.41 | $1.76M | 1,768,140 | SEC↗ |
| Harwin Peter Evan | Director, 10% Owner | P Buy | 2025-12-04 | 2025-12-08 | 1,360,000 | $13.41 | $18.24M | 2,747,866 | SEC↗ |
| Pinkas Jan | Chief Scientific Officer | A Award deriv | 2025-07-16 | 2025-07-16 | 142,474 | — | $0 | 142,474 | SEC↗ |
| Lubner David Charles | Director | A Award deriv | 2025-06-23 | 2025-06-23 | 9,023 | — | $0 | 9,023 | SEC↗ |
| Balcom Alexandra | Director | A Award deriv | 2025-06-23 | 2025-06-23 | 9,023 | — | $0 | 9,023 | SEC↗ |
| Violin Jonathan | Director | A Award deriv | 2025-06-23 | 2025-06-23 | 9,023 | — | $0 | 9,023 | SEC↗ |
| Harwin Peter Evan | Director, 10% Owner | A Award deriv | 2025-06-23 | 2025-06-23 | 9,023 | — | $0 | 9,023 | SEC↗ |
| Moran Susan | Director | A Award deriv | 2025-06-23 | 2025-06-23 | 9,023 | — | $0 | 9,023 | SEC↗ |
| BVF GP HOLDINGS LLC | 10% Owner | J Other deriv | 2025-06-13 | 2025-06-17 | 304,098 | — | $0 | 304,098 | SEC↗ |
| BVF GP HOLDINGS LLC | 10% Owner | J Other deriv | 2025-06-13 | 2025-06-17 | 257,515 | — | $0 | 257,515 | SEC↗ |
| BVF GP HOLDINGS LLC | 10% Owner | J Other deriv | 2025-06-13 | 2025-06-17 | 25,944 | — | $0 | 25,944 | SEC↗ |
| BVF GP HOLDINGS LLC | 10% Owner | J Other | 2025-06-13 | 2025-06-17 | 657,308 | — | $0 | 707,116 | SEC↗ |
| BVF GP HOLDINGS LLC | 10% Owner | J Other | 2025-06-13 | 2025-06-17 | 556,617 | — | $0 | 593,740 | SEC↗ |
| BVF GP HOLDINGS LLC | 10% Owner | J Other | 2025-06-13 | 2025-06-17 | 56,079 | — | $0 | 62,383 | SEC↗ |
| GNI Hong Kong Ltd | 10% Owner | J Other deriv | 2023-10-27 | 2023-10-27 | 10,577 | — | $0 | 0 | SEC↗ |
| GNI Hong Kong Ltd | 10% Owner | J Other | 2023-10-27 | 2023-10-27 | 5,371,304 | — | $0 | 0 | SEC↗ |
| LAWLOR AUGUSTINE | Director | D To issuer | 2023-08-31 | 2023-09-01 | 25 | — | $0 | 0 | SEC↗ |
| LAWLOR AUGUSTINE | Director | D To issuer | 2023-08-31 | 2023-09-01 | 24 | — | $0 | 0 | SEC↗ |
| GNI Hong Kong Ltd | 10% Owner | D To issuer | 2023-08-31 | 2023-09-01 | 895 | — | $0 | 0 | SEC↗ |
| GNI Hong Kong Ltd | 10% Owner | D To issuer | 2023-08-31 | 2023-09-01 | 5,371 | — | $0 | 0 | SEC↗ |
| USMAN NASSIM | President & CEO | D To issuer | 2023-08-31 | 2023-09-01 | 25 | — | $0 | 0 | SEC↗ |
| USMAN NASSIM | President & CEO | D To issuer | 2023-08-31 | 2023-09-01 | 8 | — | $0 | 0 | SEC↗ |
| USMAN NASSIM | President & CEO | D To issuer | 2023-08-31 | 2023-09-01 | 1 | — | $0 | 0 | SEC↗ |
| Hunt Andrea | Director | D To issuer | 2023-08-31 | 2023-09-01 | 28 | — | $0 | 0 | SEC↗ |
| Miller Seline E. | SVP Finance; Interim CFO & P | D To issuer | 2023-08-31 | 2023-09-01 | 7 | — | $0 | 0 | SEC↗ |
| Blouse Grant E. | Chief Scientific Officer | P Buy | 2022-08-09 | 2022-08-10 | 3,250 | $0.47 | $1.5K | 9,417 | SEC↗ |
| Miller Seline E. | SVP Finance; Interim CFO & P | P Buy | 2022-08-09 | 2022-08-10 | 3,250 | $0.47 | $1.5K | 6,500 | SEC↗ |
| USMAN NASSIM | President & CEO | P Buy | 2022-08-09 | 2022-08-10 | 3,250 | $0.47 | $1.5K | 24,541 | SEC↗ |
| Blouse Grant E. | Chief Scientific Officer | A Award deriv | 2022-02-11 | 2022-02-23 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Miller Seline E. | SVP Finance; Interim CFO & P | A Award deriv | 2022-02-11 | 2022-02-23 | 107,500 | — | $0 | 107,500 | SEC↗ |
| Blouse Grant E. | Chief Scientific Officer | P Buy | 2022-02-09 | 2022-02-16 | 3,250 | $0.46 | $1.5K | 6,167 | SEC↗ |
| Miller Seline E. | SVP Finance; Interim CFO & P | P Buy | 2022-02-09 | 2022-02-16 | 3,250 | $0.46 | $1.5K | 3,250 | SEC↗ |
| USMAN NASSIM | President & CEO | P Buy | 2022-02-09 | 2022-02-16 | 3,250 | $0.46 | $1.5K | 21,291 | SEC↗ |
| Hunt Andrea | Director | A Award | 2022-01-07 | 2022-01-07 | 7,521 | — | $0 | 28,228 | SEC↗ |
| Ling Geoffrey M.D. | Director | A Award | 2022-01-07 | 2022-01-07 | 12,855 | — | $0 | 31,790 | SEC↗ |
| Williams Eddie | Director | A Award | 2022-01-07 | 2022-01-07 | 12,308 | — | $0 | 34,804 | SEC↗ |
| DESOUZA ERROL B | Director | A Award | 2021-10-01 | 2021-10-05 | 3,588 | — | $0 | 29,801 | SEC↗ |
| Hunt Andrea | Director | A Award | 2021-10-01 | 2021-10-05 | 1,824 | — | $0 | 20,707 | SEC↗ |
| LAWLOR AUGUSTINE | Director | A Award | 2021-10-01 | 2021-10-05 | 5,839 | — | $0 | 24,573 | SEC↗ |
| Ling Geoffrey M.D. | Director | A Award | 2021-10-01 | 2021-10-05 | 2,858 | — | $0 | 18,935 | SEC↗ |
| Williams Eddie | Director | A Award | 2021-10-01 | 2021-10-05 | 2,980 | — | $0 | 22,496 | SEC↗ |
| JEW JEANNE Y | Director | A Award deriv | 2021-09-09 | 2021-09-13 | 28,000 | — | $0 | 28,000 | SEC↗ |
| Blouse Grant E. | Chief Scientific Officer | P Buy | 2021-08-09 | 2021-08-11 | 1,163 | $3.62 | $4.2K | 2,917 | SEC↗ |
| Levy Howard | Chief Medical Officer | P Buy | 2021-08-09 | 2021-08-11 | 639 | $3.62 | $2.3K | 639 | SEC↗ |
| USMAN NASSIM | President & CEO | P Buy | 2021-08-09 | 2021-08-11 | 867 | $3.62 | $3.1K | 18,041 | SEC↗ |
| DESOUZA ERROL B | Director | A Award | 2021-07-01 | 2021-07-02 | 3,406 | — | $0 | 26,213 | SEC↗ |
| Hunt Andrea | Director | A Award | 2021-07-01 | 2021-07-02 | 2,886 | — | $0 | 18,883 | SEC↗ |
| LAWLOR AUGUSTINE | Director | A Award | 2021-07-01 | 2021-07-02 | 5,542 | — | $0 | 18,734 | SEC↗ |
| Ling Geoffrey M.D. | Director | A Award | 2021-07-01 | 2021-07-02 | 2,713 | — | $0 | 16,077 | SEC↗ |
| Williams Eddie | Director | A Award | 2021-07-01 | 2021-07-02 | 1,414 | — | $0 | 19,516 | SEC↗ |
| DESOUZA ERROL B | Director | A Award deriv | 2021-06-09 | 2021-07-02 | 14,000 | — | $0 | 14,000 | SEC↗ |
| Hunt Andrea | Director | A Award deriv | 2021-06-09 | 2021-07-02 | 14,000 | — | $0 | 14,000 | SEC↗ |
| LAWLOR AUGUSTINE | Director | A Award deriv | 2021-06-09 | 2021-07-02 | 14,000 | — | $0 | 14,000 | SEC↗ |
| Ling Geoffrey M.D. | Director | A Award deriv | 2021-06-09 | 2021-07-02 | 14,000 | — | $0 | 14,000 | SEC↗ |
| TETLOW SHARON | Director | A Award deriv | 2021-06-09 | 2021-07-02 | 14,000 | — | $0 | 14,000 | SEC↗ |
| Williams Eddie | Director | A Award deriv | 2021-06-09 | 2021-07-02 | 14,000 | — | $0 | 14,000 | SEC↗ |
| USMAN NASSIM | President & CEO | M Exercise deriv | 2021-04-05 | 2021-04-07 | 5,000 | — | $0 | 259,783 | SEC↗ |
| USMAN NASSIM | President & CEO | M Exercise | 2021-04-05 | 2021-04-07 | 5,000 | $4.63 | $23.1K | 17,174 | SEC↗ |
| DESOUZA ERROL B | Director | A Award | 2021-04-01 | 2021-04-05 | 2,926 | — | $0 | 22,807 | SEC↗ |
| Hunt Andrea | Director | A Award | 2021-04-01 | 2021-04-05 | 2,480 | — | $0 | 15,997 | SEC↗ |
| LAWLOR AUGUSTINE | Director | A Award | 2021-04-01 | 2021-04-05 | 4,761 | — | $0 | 13,192 | SEC↗ |
| Ling Geoffrey M.D. | Director | A Award | 2021-04-01 | 2021-04-05 | 2,331 | — | $0 | 13,364 | SEC↗ |
| Williams Eddie | Director | A Award | 2021-04-01 | 2021-04-05 | 1,215 | — | $0 | 18,102 | SEC↗ |
| Levy Howard | Chief Medical Officer | P Buy | 2021-02-09 | 2021-02-22 | 1,670 | $4.81 | $8.0K | 23,390 | SEC↗ |
| USMAN NASSIM | President & CEO | P Buy | 2021-02-09 | 2021-02-22 | 582 | $4.81 | $2.8K | 12,174 | SEC↗ |
| Levy Howard | Chief Medical Officer | A Award deriv | 2021-02-08 | 2021-04-26 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Musil Clinton | Chief Financial Officer | A Award deriv | 2021-02-08 | 2021-04-26 | 54,000 | — | $0 | 54,000 | SEC↗ |
| USMAN NASSIM | President & CEO | A Award deriv | 2021-02-08 | 2021-04-26 | 140,000 | — | $0 | 140,000 | SEC↗ |
| Levy Howard | Chief Medical Officer | A Award deriv | 2021-02-08 | 2021-02-10 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Musil Clinton | Chief Financial Officer | A Award deriv | 2021-02-08 | 2021-02-10 | 54,000 | — | $0 | 54,000 | SEC↗ |
| USMAN NASSIM | President & CEO | A Award deriv | 2021-02-08 | 2021-02-10 | 140,000 | — | $0 | 140,000 | SEC↗ |
| DESOUZA ERROL B | Director | A Award | 2021-01-05 | 2021-01-06 | 2,129 | — | $0 | 19,881 | SEC↗ |
| Hunt Andrea | Director | A Award | 2021-01-05 | 2021-01-06 | 1,881 | — | $0 | 13,517 | SEC↗ |
| LAWLOR AUGUSTINE | Director | A Award | 2021-01-05 | 2021-01-06 | 3,417 | — | $0 | 8,431 | SEC↗ |
| Ling Geoffrey M.D. | Director | A Award | 2021-01-05 | 2021-01-06 | 1,782 | — | $0 | 11,033 | SEC↗ |
| Williams Eddie | Director | A Award | 2021-01-05 | 2021-01-06 | 940 | — | $0 | 16,887 | SEC↗ |
| DESOUZA ERROL B | Director | A Award | 2020-10-01 | 2020-10-02 | 3,125 | — | $0 | 17,752 | SEC↗ |
| Hunt Andrea | Director | A Award | 2020-10-01 | 2020-10-02 | 2,761 | — | $0 | 11,636 | SEC↗ |
| LAWLOR AUGUSTINE | Director | A Award | 2020-10-01 | 2020-10-02 | 5,014 | — | $0 | 5,014 | SEC↗ |
| Ling Geoffrey M.D. | Director | A Award | 2020-10-01 | 2020-10-02 | 2,616 | — | $0 | 9,251 | SEC↗ |
| Williams Eddie | Director | A Award | 2020-10-01 | 2020-10-02 | 1,380 | — | $0 | 15,947 | SEC↗ |
| Levy Howard | Chief Medical Officer | P Buy | 2020-08-10 | 2020-08-12 | 1,768 | $4.81 | $8.5K | 4,268 | SEC↗ |
| USMAN NASSIM | President & CEO | P Buy | 2020-08-10 | 2020-08-12 | 582 | $4.81 | $2.8K | 11,592 | SEC↗ |
| Musil Clinton | Chief Financial Officer | A Award deriv | 2020-07-01 | 2020-07-02 | 140,000 | — | $0 | 140,000 | SEC↗ |
| DESOUZA ERROL B | Director | A Award | 2020-07-01 | 2020-07-02 | 2,129 | — | $0 | 14,627 | SEC↗ |
| Hunt Andrea | Director | A Award | 2020-07-01 | 2020-07-02 | 2,076 | — | $0 | 8,875 | SEC↗ |
| LAWLOR AUGUSTINE | Director | A Award | 2020-07-01 | 2020-07-02 | 3,673 | — | $0 | 24,215 | SEC↗ |
| Ling Geoffrey M.D. | Director | A Award | 2020-07-01 | 2020-07-02 | 1,703 | — | $0 | 6,635 | SEC↗ |
| TETLOW SHARON | Director | A Award | 2020-07-01 | 2020-07-02 | 1,703 | — | $0 | 3,635 | SEC↗ |
| Williams Eddie | Director | A Award | 2020-07-01 | 2020-07-02 | 1,011 | — | $0 | 14,567 | SEC↗ |
| DESOUZA ERROL B | Director | A Award deriv | 2020-06-11 | 2020-06-12 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Hunt Andrea | Director | A Award deriv | 2020-06-11 | 2020-06-12 | 5,000 | — | $0 | 5,000 | SEC↗ |
| LAWLOR AUGUSTINE | Director | A Award deriv | 2020-06-11 | 2020-06-12 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Ling Geoffrey M.D. | Director | A Award deriv | 2020-06-11 | 2020-06-12 | 5,000 | — | $0 | 5,000 | SEC↗ |
| TETLOW SHARON | Director | A Award deriv | 2020-06-11 | 2020-06-12 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Williams Eddie | Director | A Award deriv | 2020-06-11 | 2020-06-12 | 5,000 | — | $0 | 5,000 | SEC↗ |
| DESOUZA ERROL B | Director | A Award | 2020-04-01 | 2020-04-03 | 2,860 | — | $0 | 12,498 | SEC↗ |
| Hunt Andrea | Director | A Award | 2020-04-01 | 2020-04-03 | 1,673 | — | $0 | 6,799 | SEC↗ |
| LAWLOR AUGUSTINE | Director | A Award | 2020-04-01 | 2020-04-03 | 4,934 | — | $0 | 20,542 | SEC↗ |
| Ling Geoffrey M.D. | Director | A Award | 2020-04-01 | 2020-04-03 | 1,932 | — | $0 | 4,932 | SEC↗ |
| TETLOW SHARON | Director | A Award | 2020-04-01 | 2020-04-03 | 1,932 | — | $0 | 1,932 | SEC↗ |
| Williams Eddie | Director | A Award | 2020-04-01 | 2020-04-03 | 2,717 | — | $0 | 13,556 | SEC↗ |
| Levy Howard | Chief Medical Officer | P Buy | 2020-03-16 | 2020-03-17 | 2,500 | $4.05 | $10.1K | 2,500 | SEC↗ |
| Cai Veronica | Controller | P Buy | 2020-03-13 | 2020-03-13 | 2,000 | $4.11 | $8.2K | 7,353 | SEC↗ |
| Richard John P | Director | P Buy | 2020-03-13 | 2020-03-13 | 2,500 | $3.98 | $9.9K | 3,716 | SEC↗ |
| USMAN NASSIM | President & CEO | P Buy | 2020-03-13 | 2020-03-13 | 4,000 | $3.91 | $15.6K | 11,010 | SEC↗ |
| Williams Eddie | Director | P Buy | 2020-03-04 | 2020-03-04 | 2,000 | $5.78 | $11.6K | 10,839 | SEC↗ |
| LAWLOR AUGUSTINE | Director | S Sale | 2020-02-25 | 2020-02-25 | 69,401 | $6.10 | $423.3K | 0 | SEC↗ |
| Ling Geoffrey M.D. | Director | P Buy | 2020-02-25 | 2020-02-27 | 3,000 | $6.23 | $18.7K | 3,000 | SEC↗ |
| Cai Veronica | Controller | A Award | 2020-02-10 | 2020-02-12 | 1,678 | $6.23 | $10.5K | 5,353 | SEC↗ |
| Levy Howard | Chief Medical Officer | A Award | 2020-02-10 | 2020-02-12 | 1,358 | $6.23 | $8.5K | 1,358 | SEC↗ |
| USMAN NASSIM | President & CEO | A Award | 2020-02-10 | 2020-02-12 | 430 | $6.23 | $2.7K | 7,010 | SEC↗ |
| Levy Howard | Chief Medical Officer | A Award deriv | 2020-01-23 | 2020-01-27 | 45,000 | — | $0 | 45,000 | SEC↗ |
| USMAN NASSIM | President & CEO | A Award deriv | 2020-01-23 | 2020-01-27 | 115,000 | — | $0 | 115,000 | SEC↗ |
| Cai Veronica | Controller | A Award deriv | 2020-01-23 | 2020-01-27 | 12,000 | — | $0 | 12,000 | SEC↗ |
| Ling Geoffrey M.D. | Director | A Award deriv | 2020-01-15 | 2020-01-17 | 10,000 | — | $0 | 10,000 | SEC↗ |
| TETLOW SHARON | Director | A Award deriv | 2020-01-15 | 2020-01-17 | 10,000 | — | $0 | 10,000 | SEC↗ |
| DESOUZA ERROL B | Director | A Award | 2020-01-02 | 2020-01-02 | 1,835 | — | $0 | 9,638 | SEC↗ |
| Hunt Andrea | Director | A Award | 2020-01-02 | 2020-01-02 | 1,073 | — | $0 | 5,126 | SEC↗ |
| LAWLOR AUGUSTINE | Director | A Award | 2020-01-02 | 2020-01-02 | 3,166 | — | $0 | 15,608 | SEC↗ |
| Williams Eddie | Director | A Award | 2020-01-02 | 2020-01-02 | 1,743 | — | $0 | 8,839 | SEC↗ |
| DESOUZA ERROL B | Director | A Award | 2019-10-01 | 2019-10-02 | 2,545 | — | $0 | 7,803 | SEC↗ |
| Hunt Andrea | Director | A Award | 2019-10-01 | 2019-10-02 | 1,489 | — | $0 | 4,053 | SEC↗ |
| LAWLOR AUGUSTINE | Director | A Award | 2019-10-01 | 2019-10-02 | 4,391 | — | $0 | 12,442 | SEC↗ |
| Williams Eddie | Director | A Award | 2019-10-01 | 2019-10-02 | 2,418 | — | $0 | 7,096 | SEC↗ |
| Cai Veronica | Controller | A Award deriv | 2019-09-16 | 2020-01-27 | 3,000 | — | $0 | 3,000 | SEC↗ |
| USMAN NASSIM | President & CEO | A Award | 2019-08-12 | 2019-08-12 | 413 | $6.51 | $2.7K | 6,580 | SEC↗ |
| Payne Fletcher | Chief Financial Officer | A Award | 2019-08-12 | 2019-08-12 | 1,180 | $6.51 | $7.7K | 3,744 | SEC↗ |
| DESOUZA ERROL B | Director | A Award | 2019-07-01 | 2019-07-02 | 1,810 | — | $0 | 5,258 | SEC↗ |
| Hunt Andrea | Director | A Award | 2019-07-01 | 2019-07-02 | 1,036 | — | $0 | 2,564 | SEC↗ |
| LAWLOR AUGUSTINE | Director | A Award | 2019-07-01 | 2019-07-02 | 2,905 | — | $0 | 8,051 | SEC↗ |
| Williams Eddie | Director | A Award | 2019-07-01 | 2019-07-02 | 1,642 | — | $0 | 4,678 | SEC↗ |
| DESOUZA ERROL B | Director | A Award deriv | 2019-06-13 | 2019-06-17 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Hunt Andrea | Director | A Award deriv | 2019-06-13 | 2019-06-17 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Richard John P | Director | A Award deriv | 2019-06-13 | 2019-06-17 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Williams Eddie | Director | A Award deriv | 2019-06-13 | 2019-06-17 | 5,000 | — | $0 | 5,000 | SEC↗ |
| LAWLOR AUGUSTINE | Director | A Award deriv | 2019-06-13 | 2019-06-17 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Richard John P | Director | P Buy | 2019-05-24 | 2019-05-28 | 1,000 | $8.03 | $8.0K | 1,216 | SEC↗ |
| Levy Howard | Chief Medical Officer | M Exercise | 2019-05-21 | 2019-05-22 | 4,400 | $4.63 | $20.4K | 16,094 | SEC↗ |
| Levy Howard | Chief Medical Officer | G Gift | 2019-05-21 | 2019-05-22 | 16,094 | — | $0 | 16,094 | SEC↗ |
| USMAN NASSIM | President & CEO | G Gift | 2019-05-21 | 2019-05-22 | 4,400 | — | $0 | 8,456 | SEC↗ |
| USMAN NASSIM | President & CEO | G Gift | 2019-05-21 | 2019-05-22 | 4,400 | — | $0 | 6,167 | SEC↗ |
| USMAN NASSIM | President & CEO | M Exercise | 2019-05-21 | 2019-05-22 | 4,400 | $4.63 | $20.4K | 10,567 | SEC↗ |
| Levy Howard | Chief Medical Officer | M Exercise deriv | 2019-05-20 | 2019-05-22 | 4,400 | — | $0 | 81,218 | SEC↗ |
| USMAN NASSIM | President & CEO | M Exercise deriv | 2019-05-20 | 2019-05-22 | 4,400 | — | $0 | 264,783 | SEC↗ |
| DESOUZA ERROL B | Director | A Award | 2019-04-01 | 2019-04-02 | 1,504 | — | $0 | 3,448 | SEC↗ |
| Hunt Andrea | Director | A Award | 2019-04-01 | 2019-04-02 | 717 | — | $0 | 1,528 | SEC↗ |
| LAWLOR AUGUSTINE | Director | A Award | 2019-04-01 | 2019-04-02 | 2,414 | — | $0 | 5,146 | SEC↗ |
| Williams Eddie | Director | A Award | 2019-04-01 | 2019-04-02 | 1,364 | — | $0 | 3,036 | SEC↗ |
| Levy Howard | Chief Medical Officer | A Award | 2019-02-11 | 2019-02-13 | 2,485 | $7.04 | $17.5K | 11,867 | SEC↗ |
| USMAN NASSIM | President & CEO | A Award | 2019-02-11 | 2019-02-13 | 350 | $7.04 | $2.5K | 6,167 | SEC↗ |
| Payne Fletcher | Chief Financial Officer | A Award | 2019-02-11 | 2019-02-13 | 1,002 | $7.04 | $7.1K | 3,731 | SEC↗ |
| Payne Fletcher | Chief Financial Officer | M Exercise deriv | 2019-02-04 | 2019-02-04 | 1,503 | — | $0 | 73,497 | SEC↗ |
| Payne Fletcher | Chief Financial Officer | M Exercise | 2019-02-04 | 2019-02-04 | 1,503 | $4.63 | $7.0K | 3,230 | SEC↗ |
| USMAN NASSIM | President & CEO | M Exercise deriv | 2019-01-31 | 2019-02-04 | 5,729 | — | $0 | 269,271 | SEC↗ |
| Levy Howard | Chief Medical Officer | M Exercise deriv | 2019-01-31 | 2019-02-04 | 1,500 | — | $0 | 93,500 | SEC↗ |
| USMAN NASSIM | President & CEO | M Exercise | 2019-01-31 | 2019-02-04 | 5,729 | $4.63 | $26.5K | 11,041 | SEC↗ |
| Levy Howard | Chief Medical Officer | M Exercise | 2019-01-31 | 2019-02-04 | 1,500 | $4.63 | $6.9K | 9,382 | SEC↗ |
| Levy Howard | Chief Medical Officer | A Award deriv | 2019-01-24 | 2019-01-28 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Payne Fletcher | Chief Financial Officer | A Award deriv | 2019-01-24 | 2019-01-28 | 38,000 | — | $0 | 38,000 | SEC↗ |
| USMAN NASSIM | President and CEO | A Award deriv | 2019-01-24 | 2019-01-28 | 80,000 | — | $0 | 80,000 | SEC↗ |
| DESOUZA ERROL B | Director | A Award | 2018-12-31 | 2019-01-03 | 1,703 | — | $0 | 1,944 | SEC↗ |
| Hunt Andrea | Director | A Award | 2018-12-31 | 2019-01-03 | 811 | — | $0 | 811 | SEC↗ |
| LAWLOR AUGUSTINE | Director | A Award | 2018-12-31 | 2019-01-03 | 2,732 | — | $0 | 2,732 | SEC↗ |
| Williams Eddie | Director | A Award | 2018-12-31 | 2019-01-03 | 1,544 | — | $0 | 1,672 | SEC↗ |
| Levy Howard | Chief Medical Officer | M Exercise deriv | 2018-11-26 | 2018-11-27 | 149 | — | $0 | 87,118 | SEC↗ |
| Levy Howard | Chief Medical Officer | M Exercise | 2018-11-26 | 2018-11-27 | 149 | $4.63 | $690 | 7,709 | SEC↗ |
| Levy Howard | Chief Medical Officer | M Exercise deriv | 2018-11-16 | 2018-11-16 | 173 | — | $0 | 87,267 | SEC↗ |
| Levy Howard | Chief Medical Officer | S Sale | 2018-11-16 | 2018-11-16 | 173 | $11.00 | $1.9K | 7,560 | SEC↗ |
| Levy Howard | Chief Medical Officer | M Exercise | 2018-11-16 | 2018-11-16 | 173 | $4.63 | $801 | 7,733 | SEC↗ |
| HILL STEPHEN A | Director | D To issuer | 2018-09-06 | 2018-09-06 | 190 | $10.07 | $1.9K | 1,190 | SEC↗ |
| Levy Howard | Chief Medical Officer | A Award deriv | 2018-07-30 | 2018-08-01 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Payne Fletcher | Chief Financial Officer | A Award deriv | 2018-07-30 | 2018-08-01 | 25,000 | — | $0 | 25,000 | SEC↗ |
| USMAN NASSIM | President & CEO | A Award deriv | 2018-07-30 | 2018-08-01 | 75,000 | — | $0 | 75,000 | SEC↗ |
| DESOUZA ERROL B | Director | A Award deriv | 2018-06-13 | 2018-06-15 | 5,000 | — | $0 | 5,000 | SEC↗ |
| HILL STEPHEN A | Director | A Award deriv | 2018-06-13 | 2018-06-15 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Hunt Andrea | Director | A Award deriv | 2018-06-13 | 2018-06-15 | 5,000 | — | $0 | 5,000 | SEC↗ |
| LAWLOR AUGUSTINE | Director | A Award deriv | 2018-06-13 | 2018-06-15 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Richard John P | Director | A Award deriv | 2018-06-13 | 2018-06-15 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Williams Eddie | Director | A Award deriv | 2018-06-13 | 2018-06-15 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Levy Howard | Chief Medical Officer | M Exercise deriv | 2018-05-03 | 2018-05-04 | 7,560 | — | $0 | 87,440 | SEC↗ |
| Levy Howard | Chief Medical Officer | M Exercise | 2018-05-03 | 2018-05-04 | 7,560 | $4.63 | $35.0K | 7,560 | SEC↗ |
| USMAN NASSIM | President & CEO | G Gift | 2018-04-09 | 2018-04-11 | 88 | — | $0 | 0 | SEC↗ |
| USMAN NASSIM | President & CEO | G Gift | 2018-04-09 | 2018-04-11 | 88 | — | $0 | 4,144 | SEC↗ |
| USMAN NASSIM | President & CEO | M Exercise deriv | 2018-04-04 | 2018-04-06 | 88 | — | $0 | 274,912 | SEC↗ |
| USMAN NASSIM | President & CEO | M Exercise | 2018-04-04 | 2018-04-06 | 88 | $4.63 | $407 | 88 | SEC↗ |
| Payne Fletcher | Chief Financial Officer | M Exercise deriv | 2018-03-26 | 2018-03-28 | 59 | — | $0 | 74,941 | SEC↗ |
| Payne Fletcher | Chief Financial Officer | M Exercise | 2018-03-26 | 2018-03-28 | 59 | $4.63 | $273 | 59 | SEC↗ |
| DEERFIELD MANAGEMENT COMPANY, | 10% Owner | S Sale | 2018-03-08 | 2018-03-08 | 8,123 | $29.03 | $235.8K | 1,113,222 | SEC↗ |
| DEERFIELD MANAGEMENT COMPANY, | 10% Owner | S Sale | 2018-03-08 | 2018-03-08 | 1,194 | $30.00 | $35.8K | 1,121,345 | SEC↗ |
| Deerfield Mgmt L.P. | 10% Owner | S Sale | 2018-03-08 | 2018-03-21 | 5,890 | $29.03 | $171.0K | 807,257 | SEC↗ |
| Deerfield Mgmt L.P. | 10% Owner | S Sale | 2018-03-08 | 2018-03-21 | 866 | $30.00 | $26.0K | 813,147 | SEC↗ |
| Deerfield Mgmt L.P. | 10% Owner | S Sale | 2018-03-08 | 2018-03-21 | 2,233 | $29.03 | $64.8K | 305,965 | SEC↗ |
| Deerfield Mgmt L.P. | 10% Owner | S Sale | 2018-03-08 | 2018-03-21 | 328 | $30.00 | $9.8K | 308,198 | SEC↗ |
| DEERFIELD MANAGEMENT COMPANY, | 10% Owner | S Sale | 2018-03-07 | 2018-03-08 | 10,000 | $30.00 | $300.0K | 1,122,539 | SEC↗ |
| Deerfield Mgmt L.P. | 10% Owner | S Sale | 2018-03-07 | 2018-03-21 | 2,748 | $30.00 | $82.4K | 308,526 | SEC↗ |
| Deerfield Mgmt L.P. | 10% Owner | S Sale | 2018-03-07 | 2018-03-21 | 7,252 | $30.00 | $217.6K | 814,013 | SEC↗ |
| DEERFIELD MANAGEMENT COMPANY, | 10% Owner | S Sale | 2018-03-06 | 2018-03-08 | 39,300 | $31.18 | $1.23M | 1,132,539 | SEC↗ |
| DEERFIELD MANAGEMENT COMPANY, | 10% Owner | S Sale | 2018-03-06 | 2018-03-08 | 13,161 | $29.94 | $394.0K | 1,171,839 | SEC↗ |
| Deerfield Mgmt L.P. | 10% Owner | S Sale | 2018-03-06 | 2018-03-21 | 10,802 | $31.18 | $336.8K | 311,274 | SEC↗ |
| Deerfield Mgmt L.P. | 10% Owner | S Sale | 2018-03-06 | 2018-03-21 | 28,498 | $31.18 | $888.6K | 821,265 | SEC↗ |
| Deerfield Mgmt L.P. | 10% Owner | S Sale | 2018-03-06 | 2018-03-21 | 3,617 | $29.94 | $108.3K | 322,076 | SEC↗ |
| Deerfield Mgmt L.P. | 10% Owner | S Sale | 2018-03-06 | 2018-03-21 | 9,544 | $29.94 | $285.7K | 849,763 | SEC↗ |
| DESOUZA ERROL B | Director | J Other deriv | 2018-02-20 | 2018-02-22 | 4,679 | — | $0 | 0 | SEC↗ |
| DESOUZA ERROL B | Director | J Other deriv | 2018-02-20 | 2018-02-22 | 0 | — | $0 | 0 | SEC↗ |
| HILL STEPHEN A | Director | J Other deriv | 2018-02-20 | 2018-02-22 | 21,600 | — | $0 | 0 | SEC↗ |
| HILL STEPHEN A | Director | J Other deriv | 2018-02-20 | 2018-02-22 | 0 | — | $0 | 0 | SEC↗ |
| Richard John P | Director | J Other deriv | 2018-02-20 | 2018-02-22 | 0 | — | $0 | 0 | SEC↗ |
| SELICK HAROLD E | Director | A Award deriv | 2018-01-16 | 2018-01-18 | 197 | — | $0 | 197 | SEC↗ |
| SELICK HAROLD E | Director | D To issuer deriv | 2018-01-16 | 2018-01-18 | 197 | — | $0 | 0 | SEC↗ |
| SELICK HAROLD E | Director | D To issuer deriv | 2018-01-16 | 2018-01-18 | 550 | — | $0 | 0 | SEC↗ |
| SELICK HAROLD E | Director | A Award deriv | 2018-01-16 | 2018-01-18 | 550 | — | $0 | 550 | SEC↗ |
| SELICK HAROLD E | Director | D To issuer deriv | 2018-01-16 | 2018-01-18 | 450 | — | $0 | 0 | SEC↗ |
| SELICK HAROLD E | Director | A Award deriv | 2018-01-16 | 2018-01-18 | 450 | — | $0 | 450 | SEC↗ |
| SELICK HAROLD E | Director | D To issuer deriv | 2018-01-16 | 2018-01-18 | 500 | — | $0 | 0 | SEC↗ |
| SELICK HAROLD E | Director | A Award deriv | 2018-01-16 | 2018-01-18 | 500 | — | $0 | 500 | SEC↗ |
| SELICK HAROLD E | Director | D To issuer deriv | 2018-01-16 | 2018-01-18 | 10,000 | — | $0 | 0 | SEC↗ |
| SELICK HAROLD E | Director | A Award deriv | 2018-01-16 | 2018-01-18 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Levy Howard | Chief Medical Officer | A Award deriv | 2018-01-12 | 2018-01-16 | 33,000 | — | $0 | 33,000 | SEC↗ |
| Payne Fletcher | Chief Financial Officer | A Award deriv | 2018-01-12 | 2018-01-16 | 26,000 | — | $0 | 26,000 | SEC↗ |
| USMAN NASSIM | President and CEO | A Award deriv | 2018-01-12 | 2018-01-16 | 95,000 | — | $0 | 95,000 | SEC↗ |
| Williams Eddie | Director | A Award deriv | 2018-01-02 | 2018-01-02 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Richard John P | Director | J Other deriv | 2017-12-20 | 2017-12-22 | 0 | — | $0 | 0 | SEC↗ |
| Hunt Andrea | Director | A Award deriv | 2017-10-25 | 2017-10-26 | 10,000 | — | $0 | 10,000 | SEC↗ |
| DESOUZA ERROL B | Director | A Award deriv | 2017-07-13 | 2017-07-14 | 10,000 | — | $0 | 10,000 | SEC↗ |
| HILL STEPHEN A | Director | A Award deriv | 2017-07-13 | 2017-07-14 | 10,000 | — | $0 | 10,000 | SEC↗ |
| LAWLOR AUGUSTINE | Director | A Award deriv | 2017-07-13 | 2017-07-14 | 10,000 | — | $0 | 10,000 | SEC↗ |
| SELICK HAROLD E | Director | A Award deriv | 2017-07-13 | 2017-07-14 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Richard John P | Director | A Award deriv | 2017-07-13 | 2017-07-17 | 10,000 | — | $0 | 10,000 | SEC↗ |
| USMAN NASSIM | President & CEO | A Award deriv | 2017-07-11 | 2017-07-12 | 275,000 | — | $0 | 275,000 | SEC↗ |
| Payne Fletcher | Chief Financial Officer | A Award deriv | 2017-07-11 | 2017-07-12 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Levy Howard | Chief Medical Officer | A Award deriv | 2017-07-11 | 2017-07-12 | 95,000 | — | $0 | 95,000 | SEC↗ |
| DESOUZA ERROL B | Director | A Award deriv | 2016-06-09 | 2016-06-13 | 7,500 | — | $0 | 7,500 | SEC↗ |
| HILL STEPHEN A | Director | A Award deriv | 2016-06-09 | 2016-06-13 | 7,500 | — | $0 | 7,500 | SEC↗ |
| LAWLOR AUGUSTINE | Director | A Award deriv | 2016-06-09 | 2016-06-13 | 7,500 | — | $0 | 7,500 | SEC↗ |
| Richard John P | Director | A Award deriv | 2016-06-09 | 2016-06-13 | 7,500 | — | $0 | 7,500 | SEC↗ |
| SELICK HAROLD E | Director | A Award deriv | 2016-06-09 | 2016-06-13 | 7,500 | — | $0 | 7,500 | SEC↗ |
| USMAN NASSIM | President and CEO | A Award deriv | 2016-06-09 | 2016-06-13 | 7,500 | — | $0 | 7,500 | SEC↗ |
| USMAN NASSIM | President and CEO | J Other deriv | 2016-06-09 | 2016-06-13 | 0 | — | $0 | 0 | SEC↗ |
| Levy Howard | Chief Medical Officer | A Award deriv | 2016-04-18 | 2016-04-19 | 100,000 | — | $0 | 100,000 | SEC↗ |
| HILL STEPHEN A | Director | P Buy | 2015-12-17 | 2015-12-18 | 5,000 | $2.03 | $10.1K | 20,711 | SEC↗ |
| Payne Fletcher | Chief Financial Officer | P Buy | 2015-12-17 | 2015-12-18 | 10,000 | $2.00 | $20.0K | 25,032 | SEC↗ |